nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—CYP3A5—Teniposide—lymphatic system cancer	0.0848	0.107	CbGbCtD
Lovastatin—ABCC2—Vincristine—lymphatic system cancer	0.0815	0.103	CbGbCtD
Lovastatin—CYP2C19—Teniposide—lymphatic system cancer	0.0684	0.0862	CbGbCtD
Lovastatin—SLCO1A2—Methotrexate—lymphatic system cancer	0.0595	0.075	CbGbCtD
Lovastatin—CYP2C9—Teniposide—lymphatic system cancer	0.0569	0.0717	CbGbCtD
Lovastatin—SLCO1B1—Methotrexate—lymphatic system cancer	0.0562	0.0708	CbGbCtD
Lovastatin—CYP3A7—Vincristine—lymphatic system cancer	0.0544	0.0686	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0544	0.0686	CbGbCtD
Lovastatin—ABCC2—Methotrexate—lymphatic system cancer	0.0494	0.0622	CbGbCtD
Lovastatin—CYP3A5—Vincristine—lymphatic system cancer	0.0408	0.0515	CbGbCtD
Lovastatin—ABCB1—Mitoxantrone—lymphatic system cancer	0.0386	0.0487	CbGbCtD
Lovastatin—CYP3A4—Cytarabine—lymphatic system cancer	0.0336	0.0423	CbGbCtD
Lovastatin—CYP3A4—Teniposide—lymphatic system cancer	0.0331	0.0417	CbGbCtD
Lovastatin—ABCB1—Vincristine—lymphatic system cancer	0.0266	0.0335	CbGbCtD
Lovastatin—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0231	0.0292	CbGbCtD
Lovastatin—ABCB1—Methotrexate—lymphatic system cancer	0.0161	0.0203	CbGbCtD
Lovastatin—CYP3A4—Vincristine—lymphatic system cancer	0.0159	0.0201	CbGbCtD
Lovastatin—Chest pain—Teniposide—lymphatic system cancer	0.00104	0.00504	CcSEcCtD
Lovastatin—Confusional state—Teniposide—lymphatic system cancer	0.00101	0.00487	CcSEcCtD
Lovastatin—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.000997	0.00482	CcSEcCtD
Lovastatin—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.000996	0.00482	CcSEcCtD
Lovastatin—Infection—Teniposide—lymphatic system cancer	0.000991	0.0048	CcSEcCtD
Lovastatin—Thrombocytopenia—Teniposide—lymphatic system cancer	0.000976	0.00473	CcSEcCtD
Lovastatin—Malaise—Fludarabine—lymphatic system cancer	0.000968	0.00469	CcSEcCtD
Lovastatin—Leukopenia—Fludarabine—lymphatic system cancer	0.000961	0.00465	CcSEcCtD
Lovastatin—Pruritus—Mechlorethamine—lymphatic system cancer	0.000957	0.00463	CcSEcCtD
Lovastatin—Anorexia—Teniposide—lymphatic system cancer	0.000951	0.0046	CcSEcCtD
Lovastatin—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000926	0.00448	CcSEcCtD
Lovastatin—Myalgia—Fludarabine—lymphatic system cancer	0.000914	0.00443	CcSEcCtD
Lovastatin—Arthralgia—Fludarabine—lymphatic system cancer	0.000914	0.00443	CcSEcCtD
Lovastatin—Discomfort—Fludarabine—lymphatic system cancer	0.000903	0.00437	CcSEcCtD
Lovastatin—Dyspnoea—Teniposide—lymphatic system cancer	0.000889	0.0043	CcSEcCtD
Lovastatin—Confusional state—Fludarabine—lymphatic system cancer	0.000884	0.00428	CcSEcCtD
Lovastatin—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.000876	0.00424	CcSEcCtD
Lovastatin—Infection—Fludarabine—lymphatic system cancer	0.000871	0.00422	CcSEcCtD
Lovastatin—Erectile dysfunction—Vincristine—lymphatic system cancer	0.000867	0.0042	CcSEcCtD
Lovastatin—Decreased appetite—Teniposide—lymphatic system cancer	0.000867	0.0042	CcSEcCtD
Lovastatin—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.000862	0.00417	CcSEcCtD
Lovastatin—Vomiting—Mechlorethamine—lymphatic system cancer	0.00086	0.00416	CcSEcCtD
Lovastatin—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.000859	0.00416	CcSEcCtD
Lovastatin—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000858	0.00415	CcSEcCtD
Lovastatin—Urinary tract infection—Carmustine—lymphatic system cancer	0.000855	0.00414	CcSEcCtD
Lovastatin—Rash—Mechlorethamine—lymphatic system cancer	0.000853	0.00413	CcSEcCtD
Lovastatin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000852	0.00413	CcSEcCtD
Lovastatin—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.000845	0.00409	CcSEcCtD
Lovastatin—Flushing—Bleomycin—lymphatic system cancer	0.000839	0.00406	CcSEcCtD
Lovastatin—Anorexia—Fludarabine—lymphatic system cancer	0.000835	0.00404	CcSEcCtD
Lovastatin—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.000823	0.00398	CcSEcCtD
Lovastatin—Feeling abnormal—Teniposide—lymphatic system cancer	0.000822	0.00398	CcSEcCtD
Lovastatin—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000815	0.00395	CcSEcCtD
Lovastatin—Chills—Bleomycin—lymphatic system cancer	0.000812	0.00393	CcSEcCtD
Lovastatin—Nausea—Mechlorethamine—lymphatic system cancer	0.000803	0.00389	CcSEcCtD
Lovastatin—Alopecia—Bleomycin—lymphatic system cancer	0.000799	0.00387	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000799	0.00387	CcSEcCtD
Lovastatin—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.000795	0.00385	CcSEcCtD
Lovastatin—Urticaria—Teniposide—lymphatic system cancer	0.000792	0.00384	CcSEcCtD
Lovastatin—Abdominal pain—Teniposide—lymphatic system cancer	0.000788	0.00382	CcSEcCtD
Lovastatin—Body temperature increased—Teniposide—lymphatic system cancer	0.000788	0.00382	CcSEcCtD
Lovastatin—Paraesthesia—Fludarabine—lymphatic system cancer	0.000787	0.00381	CcSEcCtD
Lovastatin—Dyspnoea—Fludarabine—lymphatic system cancer	0.000781	0.00378	CcSEcCtD
Lovastatin—Dyspepsia—Fludarabine—lymphatic system cancer	0.000772	0.00373	CcSEcCtD
Lovastatin—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000767	0.00371	CcSEcCtD
Lovastatin—Decreased appetite—Fludarabine—lymphatic system cancer	0.000762	0.00369	CcSEcCtD
Lovastatin—Fatigue—Fludarabine—lymphatic system cancer	0.000756	0.00366	CcSEcCtD
Lovastatin—Constipation—Fludarabine—lymphatic system cancer	0.000749	0.00363	CcSEcCtD
Lovastatin—Pain—Fludarabine—lymphatic system cancer	0.000749	0.00363	CcSEcCtD
Lovastatin—Vasculitis—Methotrexate—lymphatic system cancer	0.000746	0.00361	CcSEcCtD
Lovastatin—Hypersensitivity—Teniposide—lymphatic system cancer	0.000735	0.00356	CcSEcCtD
Lovastatin—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000734	0.00355	CcSEcCtD
Lovastatin—Flushing—Carmustine—lymphatic system cancer	0.000733	0.00355	CcSEcCtD
Lovastatin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000731	0.00354	CcSEcCtD
Lovastatin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000722	0.0035	CcSEcCtD
Lovastatin—Asthenia—Teniposide—lymphatic system cancer	0.000715	0.00346	CcSEcCtD
Lovastatin—Malaise—Bleomycin—lymphatic system cancer	0.00071	0.00344	CcSEcCtD
Lovastatin—Pruritus—Teniposide—lymphatic system cancer	0.000706	0.00342	CcSEcCtD
Lovastatin—Leukopenia—Bleomycin—lymphatic system cancer	0.000705	0.00341	CcSEcCtD
Lovastatin—Alopecia—Carmustine—lymphatic system cancer	0.000698	0.00338	CcSEcCtD
Lovastatin—Body temperature increased—Fludarabine—lymphatic system cancer	0.000693	0.00335	CcSEcCtD
Lovastatin—Diarrhoea—Teniposide—lymphatic system cancer	0.000682	0.0033	CcSEcCtD
Lovastatin—Myalgia—Bleomycin—lymphatic system cancer	0.00067	0.00325	CcSEcCtD
Lovastatin—Chest pain—Bleomycin—lymphatic system cancer	0.00067	0.00325	CcSEcCtD
Lovastatin—Alopecia—Vincristine—lymphatic system cancer	0.000666	0.00322	CcSEcCtD
Lovastatin—Back pain—Carmustine—lymphatic system cancer	0.000665	0.00322	CcSEcCtD
Lovastatin—Discomfort—Bleomycin—lymphatic system cancer	0.000662	0.00321	CcSEcCtD
Lovastatin—Chills—Mitoxantrone—lymphatic system cancer	0.000659	0.00319	CcSEcCtD
Lovastatin—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000652	0.00315	CcSEcCtD
Lovastatin—Alopecia—Mitoxantrone—lymphatic system cancer	0.000649	0.00314	CcSEcCtD
Lovastatin—Confusional state—Bleomycin—lymphatic system cancer	0.000648	0.00314	CcSEcCtD
Lovastatin—Vision blurred—Carmustine—lymphatic system cancer	0.000648	0.00314	CcSEcCtD
Lovastatin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000646	0.00313	CcSEcCtD
Lovastatin—Tremor—Carmustine—lymphatic system cancer	0.000644	0.00312	CcSEcCtD
Lovastatin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000643	0.00311	CcSEcCtD
Lovastatin—Infection—Bleomycin—lymphatic system cancer	0.000638	0.00309	CcSEcCtD
Lovastatin—Back pain—Vincristine—lymphatic system cancer	0.000635	0.00307	CcSEcCtD
Lovastatin—Vomiting—Teniposide—lymphatic system cancer	0.000634	0.00307	CcSEcCtD
Lovastatin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000629	0.00305	CcSEcCtD
Lovastatin—Asthenia—Fludarabine—lymphatic system cancer	0.000629	0.00304	CcSEcCtD
Lovastatin—Rash—Teniposide—lymphatic system cancer	0.000629	0.00304	CcSEcCtD
Lovastatin—Dermatitis—Teniposide—lymphatic system cancer	0.000628	0.00304	CcSEcCtD
Lovastatin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000626	0.00303	CcSEcCtD
Lovastatin—Headache—Teniposide—lymphatic system cancer	0.000625	0.00302	CcSEcCtD
Lovastatin—Pruritus—Fludarabine—lymphatic system cancer	0.00062	0.003	CcSEcCtD
Lovastatin—Back pain—Mitoxantrone—lymphatic system cancer	0.000618	0.00299	CcSEcCtD
Lovastatin—Leukopenia—Carmustine—lymphatic system cancer	0.000615	0.00298	CcSEcCtD
Lovastatin—Anorexia—Bleomycin—lymphatic system cancer	0.000613	0.00297	CcSEcCtD
Lovastatin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000602	0.00292	CcSEcCtD
Lovastatin—Photosensitivity—Methotrexate—lymphatic system cancer	0.000602	0.00291	CcSEcCtD
Lovastatin—Diarrhoea—Fludarabine—lymphatic system cancer	0.0006	0.0029	CcSEcCtD
Lovastatin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000593	0.00287	CcSEcCtD
Lovastatin—Nausea—Teniposide—lymphatic system cancer	0.000592	0.00287	CcSEcCtD
Lovastatin—Vertigo—Vincristine—lymphatic system cancer	0.000589	0.00285	CcSEcCtD
Lovastatin—Hepatic failure—Methotrexate—lymphatic system cancer	0.000588	0.00285	CcSEcCtD
Lovastatin—Leukopenia—Vincristine—lymphatic system cancer	0.000587	0.00284	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000585	0.00283	CcSEcCtD
Lovastatin—Myalgia—Carmustine—lymphatic system cancer	0.000585	0.00283	CcSEcCtD
Lovastatin—Chest pain—Carmustine—lymphatic system cancer	0.000585	0.00283	CcSEcCtD
Lovastatin—Anxiety—Carmustine—lymphatic system cancer	0.000583	0.00282	CcSEcCtD
Lovastatin—Paraesthesia—Bleomycin—lymphatic system cancer	0.000577	0.00279	CcSEcCtD
Lovastatin—Malaise—Mitoxantrone—lymphatic system cancer	0.000576	0.00279	CcSEcCtD
Lovastatin—Dyspnoea—Bleomycin—lymphatic system cancer	0.000573	0.00277	CcSEcCtD
Lovastatin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000572	0.00277	CcSEcCtD
Lovastatin—Confusional state—Carmustine—lymphatic system cancer	0.000566	0.00274	CcSEcCtD
Lovastatin—Decreased appetite—Bleomycin—lymphatic system cancer	0.000559	0.0027	CcSEcCtD
Lovastatin—Myalgia—Vincristine—lymphatic system cancer	0.000559	0.0027	CcSEcCtD
Lovastatin—Infection—Carmustine—lymphatic system cancer	0.000557	0.0027	CcSEcCtD
Lovastatin—Vomiting—Fludarabine—lymphatic system cancer	0.000557	0.0027	CcSEcCtD
Lovastatin—Rash—Fludarabine—lymphatic system cancer	0.000553	0.00268	CcSEcCtD
Lovastatin—Dermatitis—Fludarabine—lymphatic system cancer	0.000552	0.00267	CcSEcCtD
Lovastatin—Pain—Bleomycin—lymphatic system cancer	0.00055	0.00266	CcSEcCtD
Lovastatin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000549	0.00266	CcSEcCtD
Lovastatin—Headache—Fludarabine—lymphatic system cancer	0.000549	0.00266	CcSEcCtD
Lovastatin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000544	0.00263	CcSEcCtD
Lovastatin—Myalgia—Mitoxantrone—lymphatic system cancer	0.000544	0.00263	CcSEcCtD
Lovastatin—Chest pain—Mitoxantrone—lymphatic system cancer	0.000544	0.00263	CcSEcCtD
Lovastatin—Anxiety—Mitoxantrone—lymphatic system cancer	0.000542	0.00262	CcSEcCtD
Lovastatin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000537	0.0026	CcSEcCtD
Lovastatin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000535	0.00259	CcSEcCtD
Lovastatin—Anorexia—Carmustine—lymphatic system cancer	0.000535	0.00259	CcSEcCtD
Lovastatin—Infection—Vincristine—lymphatic system cancer	0.000532	0.00258	CcSEcCtD
Lovastatin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00053	0.00256	CcSEcCtD
Lovastatin—Confusional state—Mitoxantrone—lymphatic system cancer	0.000526	0.00255	CcSEcCtD
Lovastatin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000524	0.00254	CcSEcCtD
Lovastatin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000521	0.00252	CcSEcCtD
Lovastatin—Nausea—Fludarabine—lymphatic system cancer	0.000521	0.00252	CcSEcCtD
Lovastatin—Infection—Mitoxantrone—lymphatic system cancer	0.000518	0.00251	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000511	0.00247	CcSEcCtD
Lovastatin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000511	0.00247	CcSEcCtD
Lovastatin—Urticaria—Bleomycin—lymphatic system cancer	0.000511	0.00247	CcSEcCtD
Lovastatin—Anorexia—Vincristine—lymphatic system cancer	0.00051	0.00247	CcSEcCtD
Lovastatin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000508	0.00246	CcSEcCtD
Lovastatin—Insomnia—Carmustine—lymphatic system cancer	0.000507	0.00246	CcSEcCtD
Lovastatin—Paraesthesia—Carmustine—lymphatic system cancer	0.000504	0.00244	CcSEcCtD
Lovastatin—Dyspnoea—Carmustine—lymphatic system cancer	0.0005	0.00242	CcSEcCtD
Lovastatin—Anorexia—Mitoxantrone—lymphatic system cancer	0.000497	0.00241	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000488	0.00236	CcSEcCtD
Lovastatin—Decreased appetite—Carmustine—lymphatic system cancer	0.000488	0.00236	CcSEcCtD
Lovastatin—Insomnia—Vincristine—lymphatic system cancer	0.000484	0.00234	CcSEcCtD
Lovastatin—Paraesthesia—Vincristine—lymphatic system cancer	0.000481	0.00233	CcSEcCtD
Lovastatin—Pain—Carmustine—lymphatic system cancer	0.00048	0.00232	CcSEcCtD
Lovastatin—Constipation—Carmustine—lymphatic system cancer	0.00048	0.00232	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000476	0.0023	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000475	0.0023	CcSEcCtD
Lovastatin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000473	0.00229	CcSEcCtD
Lovastatin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000468	0.00227	CcSEcCtD
Lovastatin—Decreased appetite—Vincristine—lymphatic system cancer	0.000465	0.00225	CcSEcCtD
Lovastatin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000465	0.00225	CcSEcCtD
Lovastatin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000462	0.00224	CcSEcCtD
Lovastatin—Fatigue—Vincristine—lymphatic system cancer	0.000462	0.00223	CcSEcCtD
Lovastatin—Asthenia—Bleomycin—lymphatic system cancer	0.000461	0.00223	CcSEcCtD
Lovastatin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000459	0.00222	CcSEcCtD
Lovastatin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000459	0.00222	CcSEcCtD
Lovastatin—Constipation—Vincristine—lymphatic system cancer	0.000458	0.00222	CcSEcCtD
Lovastatin—Pain—Vincristine—lymphatic system cancer	0.000458	0.00222	CcSEcCtD
Lovastatin—Pruritus—Bleomycin—lymphatic system cancer	0.000455	0.0022	CcSEcCtD
Lovastatin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000453	0.00219	CcSEcCtD
Lovastatin—Eosinophilia—Methotrexate—lymphatic system cancer	0.000452	0.00219	CcSEcCtD
Lovastatin—Fatigue—Mitoxantrone—lymphatic system cancer	0.00045	0.00218	CcSEcCtD
Lovastatin—Pancreatitis—Methotrexate—lymphatic system cancer	0.000448	0.00217	CcSEcCtD
Lovastatin—Pain—Mitoxantrone—lymphatic system cancer	0.000446	0.00216	CcSEcCtD
Lovastatin—Constipation—Mitoxantrone—lymphatic system cancer	0.000446	0.00216	CcSEcCtD
Lovastatin—Body temperature increased—Carmustine—lymphatic system cancer	0.000443	0.00215	CcSEcCtD
Lovastatin—Abdominal pain—Carmustine—lymphatic system cancer	0.000443	0.00215	CcSEcCtD
Lovastatin—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000438	0.00212	CcSEcCtD
Lovastatin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000438	0.00212	CcSEcCtD
Lovastatin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00043	0.00208	CcSEcCtD
Lovastatin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000426	0.00206	CcSEcCtD
Lovastatin—Abdominal pain—Vincristine—lymphatic system cancer	0.000423	0.00205	CcSEcCtD
Lovastatin—Body temperature increased—Vincristine—lymphatic system cancer	0.000423	0.00205	CcSEcCtD
Lovastatin—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000421	0.00204	CcSEcCtD
Lovastatin—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000417	0.00202	CcSEcCtD
Lovastatin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000414	0.00201	CcSEcCtD
Lovastatin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000413	0.002	CcSEcCtD
Lovastatin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000412	0.002	CcSEcCtD
Lovastatin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000412	0.002	CcSEcCtD
Lovastatin—Vomiting—Bleomycin—lymphatic system cancer	0.000409	0.00198	CcSEcCtD
Lovastatin—Rash—Bleomycin—lymphatic system cancer	0.000405	0.00196	CcSEcCtD
Lovastatin—Dermatitis—Bleomycin—lymphatic system cancer	0.000405	0.00196	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000404	0.00196	CcSEcCtD
Lovastatin—Asthenia—Carmustine—lymphatic system cancer	0.000402	0.00195	CcSEcCtD
Lovastatin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000395	0.00191	CcSEcCtD
Lovastatin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000384	0.00186	CcSEcCtD
Lovastatin—Asthenia—Vincristine—lymphatic system cancer	0.000384	0.00186	CcSEcCtD
Lovastatin—Diarrhoea—Carmustine—lymphatic system cancer	0.000384	0.00186	CcSEcCtD
Lovastatin—Nausea—Bleomycin—lymphatic system cancer	0.000382	0.00185	CcSEcCtD
Lovastatin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000374	0.00181	CcSEcCtD
Lovastatin—Dizziness—Carmustine—lymphatic system cancer	0.000371	0.0018	CcSEcCtD
Lovastatin—Diarrhoea—Vincristine—lymphatic system cancer	0.000366	0.00177	CcSEcCtD
Lovastatin—Hepatitis—Methotrexate—lymphatic system cancer	0.000366	0.00177	CcSEcCtD
Lovastatin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000357	0.00173	CcSEcCtD
Lovastatin—Vomiting—Carmustine—lymphatic system cancer	0.000357	0.00173	CcSEcCtD
Lovastatin—Dizziness—Vincristine—lymphatic system cancer	0.000354	0.00171	CcSEcCtD
Lovastatin—Rash—Carmustine—lymphatic system cancer	0.000354	0.00171	CcSEcCtD
Lovastatin—Dermatitis—Carmustine—lymphatic system cancer	0.000353	0.00171	CcSEcCtD
Lovastatin—Headache—Carmustine—lymphatic system cancer	0.000351	0.0017	CcSEcCtD
Lovastatin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000346	0.00167	CcSEcCtD
Lovastatin—Vomiting—Vincristine—lymphatic system cancer	0.00034	0.00165	CcSEcCtD
Lovastatin—Rash—Vincristine—lymphatic system cancer	0.000338	0.00163	CcSEcCtD
Lovastatin—Dermatitis—Vincristine—lymphatic system cancer	0.000337	0.00163	CcSEcCtD
Lovastatin—Headache—Vincristine—lymphatic system cancer	0.000335	0.00162	CcSEcCtD
Lovastatin—Nausea—Carmustine—lymphatic system cancer	0.000333	0.00161	CcSEcCtD
Lovastatin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000332	0.00161	CcSEcCtD
Lovastatin—Rash—Mitoxantrone—lymphatic system cancer	0.000329	0.00159	CcSEcCtD
Lovastatin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000328	0.00159	CcSEcCtD
Lovastatin—Chills—Methotrexate—lymphatic system cancer	0.000328	0.00159	CcSEcCtD
Lovastatin—Headache—Mitoxantrone—lymphatic system cancer	0.000327	0.00158	CcSEcCtD
Lovastatin—Alopecia—Methotrexate—lymphatic system cancer	0.000323	0.00156	CcSEcCtD
Lovastatin—Nausea—Vincristine—lymphatic system cancer	0.000318	0.00154	CcSEcCtD
Lovastatin—Dysgeusia—Methotrexate—lymphatic system cancer	0.000312	0.00151	CcSEcCtD
Lovastatin—Nausea—Mitoxantrone—lymphatic system cancer	0.00031	0.0015	CcSEcCtD
Lovastatin—Back pain—Methotrexate—lymphatic system cancer	0.000308	0.00149	CcSEcCtD
Lovastatin—Vision blurred—Methotrexate—lymphatic system cancer	0.0003	0.00145	CcSEcCtD
Lovastatin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000295	0.00143	CcSEcCtD
Lovastatin—Malaise—Methotrexate—lymphatic system cancer	0.000287	0.00139	CcSEcCtD
Lovastatin—Vertigo—Methotrexate—lymphatic system cancer	0.000286	0.00138	CcSEcCtD
Lovastatin—Leukopenia—Methotrexate—lymphatic system cancer	0.000285	0.00138	CcSEcCtD
Lovastatin—Chest pain—Methotrexate—lymphatic system cancer	0.000271	0.00131	CcSEcCtD
Lovastatin—Myalgia—Methotrexate—lymphatic system cancer	0.000271	0.00131	CcSEcCtD
Lovastatin—Arthralgia—Methotrexate—lymphatic system cancer	0.000271	0.00131	CcSEcCtD
Lovastatin—Discomfort—Methotrexate—lymphatic system cancer	0.000268	0.0013	CcSEcCtD
Lovastatin—Confusional state—Methotrexate—lymphatic system cancer	0.000262	0.00127	CcSEcCtD
Lovastatin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00026	0.00126	CcSEcCtD
Lovastatin—Infection—Methotrexate—lymphatic system cancer	0.000258	0.00125	CcSEcCtD
Lovastatin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000254	0.00123	CcSEcCtD
Lovastatin—Anorexia—Methotrexate—lymphatic system cancer	0.000248	0.0012	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000237	0.00115	CcSEcCtD
Lovastatin—Insomnia—Methotrexate—lymphatic system cancer	0.000235	0.00114	CcSEcCtD
Lovastatin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000233	0.00113	CcSEcCtD
Lovastatin—Dyspnoea—Methotrexate—lymphatic system cancer	0.000232	0.00112	CcSEcCtD
Lovastatin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000229	0.00111	CcSEcCtD
Lovastatin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000226	0.00109	CcSEcCtD
Lovastatin—Fatigue—Methotrexate—lymphatic system cancer	0.000224	0.00108	CcSEcCtD
Lovastatin—Pain—Methotrexate—lymphatic system cancer	0.000222	0.00108	CcSEcCtD
Lovastatin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000214	0.00104	CcSEcCtD
Lovastatin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000212	0.00103	CcSEcCtD
Lovastatin—Urticaria—Methotrexate—lymphatic system cancer	0.000206	0.000999	CcSEcCtD
Lovastatin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000205	0.000994	CcSEcCtD
Lovastatin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000205	0.000994	CcSEcCtD
Lovastatin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000191	0.000927	CcSEcCtD
Lovastatin—Asthenia—Methotrexate—lymphatic system cancer	0.000186	0.000902	CcSEcCtD
Lovastatin—Pruritus—Methotrexate—lymphatic system cancer	0.000184	0.00089	CcSEcCtD
Lovastatin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000178	0.000861	CcSEcCtD
Lovastatin—Dizziness—Methotrexate—lymphatic system cancer	0.000172	0.000832	CcSEcCtD
Lovastatin—Vomiting—Methotrexate—lymphatic system cancer	0.000165	0.0008	CcSEcCtD
Lovastatin—Rash—Methotrexate—lymphatic system cancer	0.000164	0.000793	CcSEcCtD
Lovastatin—Dermatitis—Methotrexate—lymphatic system cancer	0.000164	0.000792	CcSEcCtD
Lovastatin—Headache—Methotrexate—lymphatic system cancer	0.000163	0.000788	CcSEcCtD
Lovastatin—Nausea—Methotrexate—lymphatic system cancer	0.000154	0.000747	CcSEcCtD
